Affiliation:
1. Centro Médico ABC
2. Instituto Nacional de Enfermedades Respiratorias
3. National Institute of Cardiology Ignacio Chavez
Abstract
Abstract
Background
ARDS due to COVID-19 infection has a unique phenotype generating a growing need to determine the existing differences that can alter existing evidence-based management strategies for ARDS, particularly those related to ventilator management.
Research Question:
What differences does the clinical profile of patients with ARDS due to COVID 19 and Non-COVID 19 have?
Study Design and Methods:
We conducted a comparative, observational, retrospective study in the ICU of a third-level hospital in Mexico City, from March 2020 through March 2022. Clinical, echocardiographic, and laboratory variables were compared between patients with ARDS due to SARS-COV2 infection and those due to other etiologies. For qualitative variables, the chi-square test was used.
Results
We enrolled 140 patients with a diagnosis of ARDS. The study group of COVID-19 etiology were younger males, higher body mass index, progressed to organ dysfunction, required more frequently renal replacement therapy, and higher SOFA score. There was no difference in rates of right ventricular dysfunction.
Interpretation:
COVID-19 ARDS exhibit much greater severity that led to higher admission and mortality rates, whilst being younger and less comorbid.
Publisher
Research Square Platform LLC
Reference38 articles.
1. Bain, Yang, Shah et al. COVID-19 vs. Non–COVID-19 ARDS.
2. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study;Balough EM;Lancet,2020
3. Lineamiento estandarizado para la. vigilancia epidemiológica y por laboratorio de la enfermedad respiratoria viral enero de 2021. Gobierno de Mexico: Secretaria de Salud; 2021.
4. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area;Davidson KW;JAMA,2020
5. FanE,BeitlerJR et al. BrochardL,CalfeeCS,FergusonND,SlutskyAS,. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med 2020;8:816–821.